A detailed history of Group One Trading, L.P. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 4,496 shares of HROW stock, worth $157,719. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,496
Holding current value
$157,719
% of portfolio
0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$20.85 - $46.47 $93,741 - $208,929
4,496 New
4,496 $202,000
Q1 2024

May 10, 2024

BUY
$9.3 - $13.23 $12,592 - $17,913
1,354 Added 7.81%
18,699 $247,000
Q4 2023

Feb 14, 2024

BUY
$8.1 - $16.36 $49,337 - $99,648
6,091 Added 54.12%
17,345 $194,000
Q3 2023

Nov 09, 2023

BUY
$14.03 - $22.08 $39,410 - $62,022
2,809 Added 33.26%
11,254 $161,000
Q2 2023

Aug 09, 2023

BUY
$17.37 - $28.08 $100,433 - $162,358
5,782 Added 217.12%
8,445 $160,000
Q1 2023

May 12, 2023

BUY
$13.84 - $21.46 $36,855 - $57,147
2,663 New
2,663 $56,000
Q2 2022

Aug 11, 2022

BUY
$5.75 - $7.74 $3,559 - $4,791
619 New
619 $5,000
Q1 2021

May 12, 2021

SELL
$6.26 - $11.03 $72,421 - $127,606
-11,569 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$4.76 - $6.93 $22,376 - $32,577
4,701 Added 68.45%
11,569 $79,000
Q3 2020

Nov 12, 2020

SELL
$4.71 - $7.36 $52,031 - $81,305
-11,047 Reduced 61.66%
6,868 $38,000
Q2 2020

Aug 13, 2020

SELL
$3.61 - $6.47 $173,052 - $310,152
-47,937 Reduced 72.8%
17,915 $93,000
Q1 2020

May 13, 2020

BUY
$3.5 - $7.31 $86,359 - $180,366
24,674 Added 59.92%
65,852 $252,000
Q4 2019

Feb 10, 2020

SELL
$4.6 - $7.88 $946,804 - $1.62 Million
-205,827 Reduced 83.33%
41,178 $320,000
Q3 2019

Nov 12, 2019

BUY
$4.89 - $8.0 $1.1 Million - $1.8 Million
224,897 Added 1017.27%
247,005 $1.39 Million
Q2 2019

Aug 09, 2019

SELL
$4.2 - $8.7 $203,242 - $421,001
-48,391 Reduced 68.64%
22,108 $192,000
Q1 2019

May 13, 2019

BUY
$4.75 - $7.1 $334,870 - $500,542
70,499 New
70,499 $351,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $950M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.